Clinical Trial Update: Randomized Therapy In Status Epilepticus [Phase 3]

View source ↗

Summary

Marinus Pharmaceuticals reports completion of a Phase 3 randomized trial for status epilepticus with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Status Epilepticus

Drugs mentioned

• ganaxolone (ganaxolone)

Snippet

Sponsor: Marinus Pharmaceuticals | Conditions: Status Epilepticus | Phase 3 | Status: COMPLETED | Results posted: 2025-05-29